HKSE - Delayed Quote HKD

Tianjin TEDA Biomedical Engineering Company Limited (8189.HK)

0.075 +0.006 (+8.70%)
As of April 24 at 9:31 AM GMT+8. Market Open.
Loading Chart for 8189.HK
DELL
  • Previous Close 0.069
  • Open 0.075
  • Bid 0.062 x --
  • Ask 0.077 x --
  • Day's Range 0.075 - 0.075
  • 52 Week Range 0.061 - 0.105
  • Volume 55,000
  • Avg. Volume 20,416
  • Market Cap (intraday) 142.125M
  • Beta (5Y Monthly) 0.09
  • PE Ratio (TTM) --
  • EPS (TTM) -0.010
  • Earnings Date May 8, 2024 - May 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of biological compound fertilizer products in the People's Republic of China. The company operates in three segments: Biological Compound Fertilizers Products; Elderly Care and Health Care Services; and Health Care Products (Wine) and Related Services. Its biological compound fertilizer products include active fertilizer, mixture with nitrogen, phosphorus, and potassium with various formula that are used for the facilitation of balanced growth of grains, fruits, and vegetables. The company is also involved in the provision of integrated elderly and health care; and elderly equipment leasing services, as well as consulting, advisory, and assessment services. In addition, it provides and licenses electroencephalography photography (EEG) diagnosis detection services; conducts EEG detection and diagnosis technology services. Further, the company engages in the research, development, manufacture, and application of biomedical science and technology projects; regional soil resources conditioning and remediation business; trading of wine and specializing in system platform development; and provision of soil environmental quality standards research services, as well as information transmission, software, and information technology service industry. Tianjin TEDA Biomedical Engineering Company Limited was incorporated in 2000 and is headquartered in Tianjin, the People's Republic of China.

www.bioteda.com

264

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 8189.HK

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

8189.HK
15.73%
HANG SENG INDEX
3.96%

1-Year Return

8189.HK
24.24%
HANG SENG INDEX
9.67%

3-Year Return

8189.HK
16.67%
HANG SENG INDEX
39.06%

5-Year Return

8189.HK
66.37%
HANG SENG INDEX
40.03%

Compare To: 8189.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 8189.HK

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    142.12M

  • Enterprise Value

    226.05M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.33

  • Price/Book (mrq)

    2.63

  • Enterprise Value/Revenue

    0.57

  • Enterprise Value/EBITDA

    47.15

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.07%

  • Return on Assets (ttm)

    -3.77%

  • Return on Equity (ttm)

    -15.05%

  • Revenue (ttm)

    398M

  • Net Income Avi to Common (ttm)

    -14.56M

  • Diluted EPS (ttm)

    -0.010

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.93M

  • Total Debt/Equity (mrq)

    129.39%

  • Levered Free Cash Flow (ttm)

    -1.99M

Company Insights: 8189.HK

People Also Watch